» Articles » PMID: 30069742

Clinicopathological Differences in Signet Ring Cell Adenocarcinoma Between Early and Advanced Gastric Cancer

Overview
Journal Gastric Cancer
Date 2018 Aug 3
PMID 30069742
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Signet ring cell adenocarcinoma is a histological classification based on the WHO classification. The presence of this specific histological type is associated with a worse pathological appearance. The prognosis of signet ring cell adenocarcinoma in gastric cancer patients after curative surgery is still under debate.

Methods: From January 1988 to December 2012, a total of 2971 patients, including 819 early and 2152 advanced gastric cancer patients underwent curative resection for gastric cancer. Among them, there were 185 cases of signet ring cell adenocarcinoma in early gastric cancer patients, while there were 570 cases in advanced gastric cancer patients.

Results: The overall incidence of signet ring cell adenocarcinoma was 25.4%. Our results showed that the 5-year overall survival rates of early gastric cancer patients with signet ring cell adenocarcinoma and non-signet ring cell adenocarcinoma were 90.7 and 83.2%, respectively (P = 0.001). The 5-year disease-free survival rates of early gastric cancer patients with signet ring cell adenocarcinoma and non-signet ring cell adenocarcinoma were 87.4 and 81.6%, respectively (P = 0.003). The 5-year overall survival rates of advanced gastric cancer patients with signet ring cell adenocarcinoma and non-signet ring cell adenocarcinoma were 32.1 and 37.9%, respectively (P = 0.041). The 5-year disease-free survival rates of advanced gastric cancer patients with signet ring cell adenocarcinoma and non-signet ring cell adenocarcinoma were 28.6 and 35.2%, respectively (P = 0.037). Signet ring cell adenocarcinoma was an independent predictor for overall survival in advanced gastric cancer (P = 0.017).

Conclusion: The clinical features and prognosis of signet ring cell adenocarcinoma are different between early and advanced gastric cancer. Signet ring cell adenocarcinoma is a poor prognostic factor in advanced gastric cancer after curative resection.

Citing Articles

Mapping the landscape of gastric signet ring cell carcinoma: Overcoming hurdles and charting new paths for advancement.

Wang S, Wang J, Chen R, Yuan Z, Cui H, Wei B World J Clin Oncol. 2025; 16(2):98983.

PMID: 39995554 PMC: 11686557. DOI: 10.5306/wjco.v16.i2.98983.


Prognostic prediction and treatment options for gastric signet ring cell carcinoma: a SEER database analysis.

Yu C, Yang J, Li H, Wang J, Jin K, Li Y Front Oncol. 2024; 14:1473798.

PMID: 39497709 PMC: 11532132. DOI: 10.3389/fonc.2024.1473798.


Development and validation of nomograms based on the SEER database for the risk factors and prognosis of distant metastasis in gastric signet ring cell carcinoma.

Shi H, Yang H, Yan S, Zhang Q, Wang X Medicine (Baltimore). 2024; 103(44):e40382.

PMID: 39496020 PMC: 11537633. DOI: 10.1097/MD.0000000000040382.


Development and validation of a tumor size-stratified prognostic nomogram for patients with gastric signet ring cell carcinoma.

Hui X, Zhou G, Zheng Y, Wang Y, Guo Q Updates Surg. 2024; 76(8):2813-2824.

PMID: 39495439 PMC: 11628570. DOI: 10.1007/s13304-024-02020-0.


Gastroesophageal signet ring cell carcinoma morbidity and mortality: A retrospective review.

Grinlinton M, Furkert C, Maurice A, Angelo N, Booth M World J Gastrointest Surg. 2024; 16(6):1629-1636.

PMID: 38983359 PMC: 11230026. DOI: 10.4240/wjgs.v16.i6.1629.


References
1.
Chon H, Hyung W, Kim C, Park S, Kim J, Park C . Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia. Ann Surg. 2016; 265(5):946-953. PMC: 5389602. DOI: 10.1097/SLA.0000000000001793. View

2.
Bamboat Z, Tang L, Vinuela E, Kuk D, Gonen M, Shah M . Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma. Ann Surg Oncol. 2014; 21(5):1678-85. DOI: 10.1245/s10434-013-3466-8. View

3.
Kwon K, Shim K, Song E, Choi J, Kim S, Jung H . Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach. Gastric Cancer. 2013; 17(1):43-53. DOI: 10.1007/s10120-013-0234-1. View

4.
Hyung W, Noh S, Lee J, Huh J, Lah K, Choi S . Early gastric carcinoma with signet ring cell histology. Cancer. 2002; 94(1):78-83. DOI: 10.1002/cncr.10120. View

5.
Messager M, Lefevre J, Pichot-Delahaye V, Souadka A, Piessen G, Mariette C . The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann Surg. 2011; 254(5):684-93. DOI: 10.1097/SLA.0b013e3182352647. View